Showing results (111-120 of 174) with videos related to
Sort By:
Pageof 18
Hepatic Oncology|June 4, 2021
Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinomaDiana Julie Leeming, Signe Holm Nielsen, Roslyn Vongsuvanh, et al.Cancer Letters|December 22, 2020
An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cellsGang Zhou, Sarah Da Won Bae, Romario Nguyen, et al.Journal of Hepatocellular Carcinoma|November 18, 2020
Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma - A Biomarker That Provides Additional Prognostic Value in AFP Positive PatientsChristina Jensen, Signe Holm Nielsen, Mohammed Eslam, et al.Metabolism: Clinical and Experimental|September 27, 2023
Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational StudyLaura Valenzuela-Vallejo, Pavlina Chrysafi, Matina Kouvari, et al.Minerva Gastroenterology|January 20, 2026
Metabolic liver disease research in the Arab world: a bibliometric analysis of trends, collaborations, and disparities (2006-2024)Mortada H El-Shabrawi, Maito Suoh, Shadan Almuhaidib, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2020
Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A CirrhosisEduardo Vilar-Gomez, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, et al.Annals of Hepatology|July 2, 2013
Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variablesMohammed Eslam, Javier Ampuero, Maria Jover, et al.Liver Cancer|March 6, 2023
Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver DiseaseHaonan Lu, Jacob George, Mohammed Eslam, et al.Diabetes Research and Clinical Practice|August 11, 2023
The first external validation of the Dallas steatosis index in biopsy-proven Non-alcoholic fatty liver Disease: A multicenter studyMatina Kouvari, Sophia C Mylonakis, Angeliki Katsarou, et al.Journal of Hepatology|March 26, 2019
KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis BRatna S Wijaya, Scott A Read, Stephen Schibeci, et al.Pageof 18